Overview
Multiminicore myopathy (also known as multiminicore disease, multicore myopathy, or minicore myopathy) is a rare inherited muscle disorder classified among the congenital myopathies. It is characterized by the presence of multiple small areas of disrupted structure (called minicores or multicores) within muscle fibers, visible on muscle biopsy. The disease primarily affects skeletal muscles, leading to muscle weakness and hypotonia (reduced muscle tone), typically presenting in infancy or early childhood. Several clinical forms have been described, including the classic form (the most common), which features axial muscle weakness, scoliosis, and respiratory insufficiency; a form with prominent external ophthalmoplegia (weakness of eye muscles); a form with hand involvement and joint contractures; and a moderate form with generalized weakness. The classic form of multiminicore myopathy is most frequently caused by recessive mutations in the SEPN1 (selenoprotein N) gene or the RYR1 (ryanodine receptor 1) gene. Mutations in RYR1 can also cause other forms of the disease. Less commonly, mutations in MYH7 and other genes have been implicated. The disease predominantly affects the musculoskeletal and respiratory systems. Patients often present with delayed motor milestones, proximal and axial muscle weakness, spinal rigidity, scoliosis, and progressive respiratory compromise that may require ventilatory support. Facial weakness and feeding difficulties may also occur in early life. Cardiac involvement is uncommon but has been reported in certain genetic subtypes. There is currently no cure for multiminicore myopathy, and treatment is supportive and multidisciplinary. Management focuses on physical therapy and rehabilitation to maintain mobility, orthopedic interventions for scoliosis, and respiratory monitoring with ventilatory support when needed. Nutritional support may be required in patients with feeding difficulties. Regular cardiac screening may be recommended depending on the genetic subtype. Genetic counseling is important for affected families. With appropriate supportive care, many patients maintain ambulation, though the clinical course and severity can vary significantly depending on the underlying genetic cause and clinical subtype.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
2 eventsShandong Provincial Hospital — NA
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina — PHASE4
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Multiminicore myopathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Multiminicore myopathy at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Multiminicore myopathy.
Community
No community posts yet. Be the first to share your experience with Multiminicore myopathy.
Start the conversation →Latest news about Multiminicore myopathy
Disease timeline:
New recruiting trial: An Empirical Study on the Mechanisms of Biopsychosocial Functional Improvement in Patients With Major Depressive Disorder Through Nature-Based Tourism Activities
A new clinical trial is recruiting patients for Multiminicore myopathy
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Multiminicore myopathy
What is Multiminicore myopathy?
Multiminicore myopathy (also known as multiminicore disease, multicore myopathy, or minicore myopathy) is a rare inherited muscle disorder classified among the congenital myopathies. It is characterized by the presence of multiple small areas of disrupted structure (called minicores or multicores) within muscle fibers, visible on muscle biopsy. The disease primarily affects skeletal muscles, leading to muscle weakness and hypotonia (reduced muscle tone), typically presenting in infancy or early childhood. Several clinical forms have been described, including the classic form (the most common),
Which specialists treat Multiminicore myopathy?
4 specialists and care centers treating Multiminicore myopathy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.